Saxenda (liraglutide) Saxenda is a GLP-1 medication appropriate for adults who: Have obesity (BMI of 30 or above) Have overweight (BMI of 27 or above) along with a weight-related comorbid condition like high blood pressure, type 2 diabetes, or high cholesterol or triglycerides It is also approved for children ages 12 and above who weigh more than 132 pounds and are considered obese
Why GLP-1 Treatments May Cause Hair Thinning The mechanism behind hair loss in patients taking GLP-1 medications is not directly related to the drug's pharmacological action on GLP-1 receptors
Promotes cognitive function Almost one-third of men will develop dementia during their lives (10)
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
Certain antidepressants, beta blockers to treat high blood pressure, statins to treat cholesterol abnormalities, psychostimulants for attention deficit hyperactivity disorder, dopamine agonists for Parkinsons disease, and acetylcholinesterase inhibitors to treat neurodegenerative diseases like Alzheimers and Parkinsons are all among the medications that have been linked to causing or aggravating distressing dreams
However, this may derive from improvements to vascular and metabolic health, rather than its effects on amyloid and tau